Literature DB >> 18228261

Visualization and experimental analysis of blood vessel formation using transgenic zebrafish.

Young Ryun Cha1, Brant M Weinstein.   

Abstract

The mechanisms of blood vessel formation have become a subject of enormous scientific and clinical interest. However, it is difficult to visualize the developing vasculature in most living animals due to the ubiquitous and deep localization of vessels within other tissues. The establishment of vascular-specific transgenic zebrafish with fluorescently "tagged" blood vessels has facilitated high-resolution imaging studies of developing blood and lymphatic vessels in vivo. Use of these transgenic lines for genetic and chemical screening, experimental manipulations, and time-lapse imaging has extended our knowledge of how complex networks of vessels assemble in vivo. Published 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18228261     DOI: 10.1002/bdrc.20103

Source DB:  PubMed          Journal:  Birth Defects Res C Embryo Today        ISSN: 1542-975X


  12 in total

Review 1.  How blood vessel networks are made and measured.

Authors:  John C Chappell; David M Wiley; Victoria L Bautch
Journal:  Cells Tissues Organs       Date:  2011-10-12       Impact factor: 2.481

2.  Use of PCR template-derived probes prevents off-target whole mount in situ hybridization in transgenic zebrafish.

Authors:  Young R Cha; Brant M Weinstein
Journal:  Zebrafish       Date:  2012-06       Impact factor: 1.985

Review 3.  Vascular development in the zebrafish.

Authors:  Aniket V Gore; Kathryn Monzo; Young R Cha; Weijun Pan; Brant M Weinstein
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

4.  Identification of vascular disruptor compounds by analysis in zebrafish embryos and mouse embryonic endothelial cells.

Authors:  Catherine W McCollum; Javier Conde-Vancells; Charu Hans; Mercedes Vazquez-Chantada; Nicole Kleinstreuer; Tamara Tal; Thomas Knudsen; Shishir S Shah; Fatima A Merchant; Richard H Finnell; Jan-Åke Gustafsson; Robert Cabrera; Maria Bondesson
Journal:  Reprod Toxicol       Date:  2016-11-10       Impact factor: 3.143

5.  Combination of reverse and chemical genetic screens reveals angiogenesis inhibitors and targets.

Authors:  Mattias Kalén; Elisabet Wallgard; Noomi Asker; Aidas Nasevicius; Elisabet Athley; Erik Billgren; Jon D Larson; Shannon A Wadman; Elizabeth Norseng; Karl J Clark; Liqun He; Linda Karlsson-Lindahl; Ann-Katrin Häger; Holger Weber; Hellmut Augustin; Tore Samuelsson; Chelsy K Kemmet; Carly M Utesch; Jeffrey J Essner; Perry B Hackett; Mats Hellström
Journal:  Chem Biol       Date:  2009-04-24

6.  Role of VEGF and tissue hypoxia in patterning of neural and vascular cells recruited to the embryonic heart.

Authors:  Hongbin Liu; Qiwei Yang; Krishnan Radhakrishnan; Dedra E Whitfield; Camille L M Everhart; Patricia Parsons-Wingerter; Steven A Fisher
Journal:  Dev Dyn       Date:  2009-11       Impact factor: 3.780

Review 7.  Lymphatic development.

Authors:  Matthew G Butler; Sumio Isogai; Brant M Weinstein
Journal:  Birth Defects Res C Embryo Today       Date:  2009-09

8.  Automated in vivo drug screen in zebrafish identifies synapse-stabilising drugs with relevance to spinal muscular atrophy.

Authors:  Ana-Maria Oprişoreanu; Hannah L Smith; Sophia Krix; Helena Chaytow; Neil O Carragher; Thomas H Gillingwater; Catherina G Becker; Thomas Becker
Journal:  Dis Model Mech       Date:  2021-04-26       Impact factor: 5.758

9.  Zebrafish bioassay-guided natural product discovery: isolation of angiogenesis inhibitors from East African medicinal plants.

Authors:  Alexander D Crawford; Sandra Liekens; Appolinary R Kamuhabwa; Jan Maes; Sebastian Munck; Roger Busson; Jef Rozenski; Camila V Esguerra; Peter A M de Witte
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

10.  Stable vascular connections and remodeling require full expression of VE-cadherin in zebrafish embryos.

Authors:  Mercedes Montero-Balaguer; Kendra Swirsding; Fabrizio Orsenigo; Franco Cotelli; Marina Mione; Elisabetta Dejana
Journal:  PLoS One       Date:  2009-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.